AI Article Synopsis

  • Researchers are exploring Mycoplasma feriruminatoris, a fast-dividing bacterium without a cell wall, as a new platform for producing and secreting complex biomolecules with therapeutic potential, overcoming previous limitations due to slow growth.
  • The study successfully developed optimal promoter sequences and identified secretion signals, validated through a luminescent reporter, to enable the effective secretion of valuable proteins like interleukins and nanobodies.
  • This work demonstrates the potential of engineering M. feriruminatoris to create functional proteins that could aid in medical research and therapeutic applications.

Article Abstract

Background: Having a simple and fast dividing organism capable of producing and exposing at its surface or secreting functional complex biomolecules with disulphide bridges is of great interest. The mycoplasma bacterial genus offers a set of relevant properties that make it an interesting chassis for such purposes, the main one being the absence of a cell wall. However, due to their slow growth, they have rarely been considered as a potential platform in this respect. This notion may be challenged with the recent discovery of Mycoplasma feriruminatoris, a species with a dividing time close to that of common microbial workhorses. So far, no tools for heterologous protein expression nor secretion have been described for it.

Results: The work presented here develops the fast-dividing M. feriruminatoris as a tool for secreting functional biomolecules of therapeutic interest that could be used for screening functional mutants as well as potentially for protein-protein interactions. Based on RNAseq, quantitative proteomics and promoter sequence comparison we have rationally designed optimal promoter sequences. Then, using in silico analysis, we have identified putative secretion signals that we validated using a luminescent reporter. The potential of the resulting secretion cassette has been shown with set of active clinically relevant proteins (interleukins and nanobodies).

Conclusions: We have engineered Mycoplasma feriruminatoris for producing and secreting functional proteins of medical interest.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11059754PMC
http://dx.doi.org/10.1186/s12934-024-02392-3DOI Listing

Publication Analysis

Top Keywords

mycoplasma feriruminatoris
12
secreting functional
12
developing platform
4
secretion
4
platform secretion
4
secretion biomolecules
4
mycoplasma
4
biomolecules mycoplasma
4
feriruminatoris
4
feriruminatoris background
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!